These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19900603)

  • 21. Tools for target identification and validation.
    Wang S; Sim TB; Kim YS; Chang YT
    Curr Opin Chem Biol; 2004 Aug; 8(4):371-7. PubMed ID: 15288246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analytical strategies for identifying drug metabolites.
    Prakash C; Shaffer CL; Nedderman A
    Mass Spectrom Rev; 2007; 26(3):340-69. PubMed ID: 17405144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The devil is still in the details--driving early drug discovery forward with biophysical experimental methods.
    Lundqvist T
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):513-9. PubMed ID: 16022188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expediting drug discovery: recent advances in fast medicinal chemistry--optimization of hits and leads.
    Edwards PJ; Allart B; Andrews MJ; Clase JA; Menet C
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):425-44. PubMed ID: 16889227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fragment-based drug design: combining philosophy with technology.
    Bartoli S; Fincham CI; Fattori D
    Curr Opin Drug Discov Devel; 2007 Jul; 10(4):422-9. PubMed ID: 17659483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New methods in pharmaceutical research: combinatorial chemistry and high throughput screening].
    Schirlin D; Galvan M; Le Fur G
    Bull Acad Natl Med; 2007; 191(4-5):727-36; discussion 736-7. PubMed ID: 18225426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yeast genomics and proteomics in drug discovery and target validation.
    Parsons AB; Geyer R; Hughes TR; Boone C
    Prog Cell Cycle Res; 2003; 5():159-66. PubMed ID: 14593709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From virtuality to reality - Virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective.
    Rester U
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):559-68. PubMed ID: 18600572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antisense and RNAi: powerful tools in drug target discovery and validation.
    Lavery KS; King TH
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):561-9. PubMed ID: 12951819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New approaches to drug discovery and development: a mechanism-based approach to pharmaceutical research and its application to BNP7787, a novel chemoprotective agent.
    Hausheer FH; Kochat H; Parker AR; Ding D; Yao S; Hamilton SE; Petluru PN; Leverett BD; Bain SH; Saxe JD
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S3-15. PubMed ID: 12819940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applications of high-throughput ADME in drug discovery.
    Kassel DB
    Curr Opin Chem Biol; 2004 Jun; 8(3):339-45. PubMed ID: 15183334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fragments, network biology and designing multiple ligands.
    Morphy R; Rankovic Z
    Drug Discov Today; 2007 Feb; 12(3-4):156-60. PubMed ID: 17275736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calculation and application of activity discriminants in lead optimization.
    Luo X; Krumrine JR; Shenvi AB; Pierson ME; Bernstein PR
    J Mol Graph Model; 2010 Nov; 29(3):372-81. PubMed ID: 20800520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis of pharmacophore screening tools.
    Sanders MP; Barbosa AJ; Zarzycka B; Nicolaes GA; Klomp JP; de Vlieg J; Del Rio A
    J Chem Inf Model; 2012 Jun; 52(6):1607-20. PubMed ID: 22646988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening library evolution through automation of solution preparation.
    Schopfer U; Höhn F; Hueber M; Girod M; Engeloch C; Popov M; Muckenschnabel I
    J Biomol Screen; 2007 Aug; 12(5):724-32. PubMed ID: 17507640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ROCK: the Roche medicinal chemistry knowledge application - design, use and impact.
    Mayweg A; Hofer U; Schnider P; Agnetti F; Galley G; Mattei P; Lucas M; Boehm HJ
    Drug Discov Today; 2011 Aug; 16(15-16):691-6. PubMed ID: 21439402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application and interpretation of free and total drug measurements in the development of biologics.
    Ahene AB
    Bioanalysis; 2011 Jun; 3(11):1287-95. PubMed ID: 21649503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analytical chemistry for drug discovery and development.
    Roda A
    Anal Bioanal Chem; 2010 Sep; 398(1):27-8. PubMed ID: 20652554
    [No Abstract]   [Full Text] [Related]  

  • 40. Medicinal chemistry matters - a call for discipline in our discipline.
    Johnstone C
    Drug Discov Today; 2012 Jun; 17(11-12):538-43. PubMed ID: 22301070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.